v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Cash flows from (used in) operating activities      
Loss for the year $ (5,476,778) $ (18,663,448) $ (18,342,796)
Items not affecting cash      
Allowance (recovery) for credit losses 10,528 (12,277) 1,450,962
Depreciation 1,445,129 1,662,113 1,854,728
Debt extinguishment costs 1,390,187 0 0
Fair value adjustment to Pref A shares liability 497,149 0 0
Income tax recovery (406,000) 0 0
Share-based payments 279,546 897,468 1,502,112
Change from lease adjustment 51,802 0 0
Loss on disposition of equipment 24,961 0 0
Accretion & accrued interest 1,513,126 724,152 723,199
Write-down of assets 0 0 423,267
Other (income) / expense 0 (1,391,746) (306,288)
Write down of inventory 988,190 0 1,078,854
Foreign exchange loss / (gain) (141,339) (40,657) (131,416)
Cash flow used in operating activities before changes in assets and liabilities 176,501 (16,824,395) (11,747,378)
Changes in working capital items:      
Accounts receivable 199,443 2,302,426 6,255,091
Inventory 654,925 7,883,289 8,752,609
Prepaids and deposits 826,284 (493,308) (419,778)
Finance lease receivables 45,001 50,230 132,138
Accounts payable and accrued liabilities (302,613) 581,983 (4,339,016)
Contingent liability (176,606) 310,000 0
Deferred revenue (7,562,306) 46,063 (337,484)
Warranty liability (44,970) 155,539 571,570
Total cash flows from (used in) operating activities (6,184,341) (5,988,173) (1,132,248)
Cash flows from (used in) investing activities      
Restricted deposits 11,950 0 (400,000)
Purchase of property and equipment 0 (83,172) (361,533)
Total cash flows from (used in) investing activities 11,950 (83,172) (761,533)
Cash flows from (used in) financing activities      
(Repayment of) / loans from related parties 6,563,037 1,377,292 (449,400)
Proceeds from (repayment of) line of credit (3,974,245) (1,479,634) 850,974
Proceeds from (repayment of) revolving term loan facility (12,104) 1,323,457 2,235,375
Proceeds from term loan facility 2,000,000 0 0
Proceeds from promissory note 0 0 30,111
Payments on lease liabilities (574,400) (553,918) (1,050,611)
Adjustments to lease liabilities (8,566) (8,567) (8,566)
Proceeds from issuance of common shares and warrants 455,095 5,325,850 520,892
Proceeds from issuance of series A convertible preferred shares 1,770,065 0 0
Equity offering costs (113,388) (884,208) (14,904)
Proceeds from exercise of stock options 0 0 209,962
Total cash flows from (used in) financing activities 6,105,494 5,100,272 2,323,833
Foreign exchange on cash 50,739 164,426 120,437
Net increase (decrease) in cash (16,158) (806,647) 550,489
Cash, beginning of year 344,244 1,150,891 600,402
Cash, end of year $ 328,086 $ 344,244 $ 1,150,891